The production of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex several-stage synthetic process. Preliminary routes focused on peptide fragment coupling, utilizing https://xanderqdwc226245.thelateblog.com/41052510/creation-and-study-implementations-of-retatrutide